Denay May, CNM
Advanced Practice Midwife · Marietta, OHNPI 1841528791
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,379 of the $1,776 with a category attached, or 77.6%. 19 manufacturers reported payments, led by Astellas Pharma US Inc at 31.0% of the total. Reporting peaked in 2023 at $579 and has fallen 57.7% since, to $245 in 2025. Among advanced practice midwife clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $28.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$550
- Mayne Pharma Commercial LLC$393
- Organon$188
- Sage Therapeutics, LLC$106
- Channel Medsystems, Inc.$75
- Biohaven Pharmaceutical Holding Company Ltd.$65
- plus $399 from 13 others
What the payments were for
- Food & beverage$1,37978%
- Education$39722%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 15 | $550 |
| Mayne Pharma Commercial LLC | 1 | $393 |
| Organon | 13 | $188 |
| Sage Therapeutics, LLC | 5 | $106 |
| Channel Medsystems, Inc. | 1 | $75 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $65 |
| Bayer | 3 | $64 |
| AbbVie | 4 | $53 |
| Exeltis, USA Inc. | 3 | $42 |
| Pfizer | 3 | $42 |
| Convatec Inc. | 1 | $31 |
| Amgen | 2 | $30 |
| Therapeuticsmd, Inc. | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Myovant Sciences Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$1,776 in reported general payments places this provider in the 90th percentile of 300 advanced practice midwife providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 27 | $313 |
| Clobetasol Propionate | 14 | $311 |
| Alendronate Sodium | 15 | $110 |
| Norethindrone | 11 | $96 |
Paid to pharmacies, not to this prescriber.
Other advanced practice midwife in Marietta
- Elizabeth NiedereggerCincinnati$76K
- Lucia JenkuskyColumbus$15K
- Hannah CackovicWorthington$12K
- Barbara FrancisPerrysburg$9K
- Rebecca Ulery TannerChillicothe$7K
- Sylvia SaikusCleveland$6K
- Chardina Murray-ManginoBoardman$3K
- Susan SommerOregon$3K
- Pamela MaddenEnglewood$3K
- Katherine BellomyWesterville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.